Therefore, it is unclear whether anti-PD-L1 antibody has the same therapeutic effect as malignant melanoma and non-small cell lung cancer, because there may be an immune escape mechanism unique to thyroid cancer. This evidence concerns the gene CD274 and thyroid gland carcinoma.